Leafly Holdings, Inc. (LFLY)

USD 1.35

(4.65%)

EBITDA Summary of Leafly Holdings, Inc.

  • Leafly Holdings, Inc.'s latest annual EBITDA in 2023 was -5.73 Million USD , up 78.71% from previous year.
  • Leafly Holdings, Inc.'s latest quarterly EBITDA in 2024 Q2 was -323 Thousand USD , up 78.36% from previous quarter.
  • Leafly Holdings, Inc. reported an annual EBITDA of 8.33 Million USD in 2022, down -173.39% from previous year.
  • Leafly Holdings, Inc. reported an annual EBITDA of -10.19 Million USD in 2021, down -15.61% from previous year.
  • Leafly Holdings, Inc. reported a quarterly EBITDA of -1.41 Million USD for 2024 Q1, down -418.9% from previous quarter.
  • Leafly Holdings, Inc. reported a quarterly EBITDA of -4.75 Million USD for 2023 Q1, up 12.91% from previous quarter.

Annual EBITDA Chart of Leafly Holdings, Inc. (2023 - 2019)

Historical Annual EBITDA of Leafly Holdings, Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -5.73 Million USD 78.71%
2022 8.33 Million USD -173.39%
2021 -10.19 Million USD -15.61%
2020 -661.21 Thousand USD 71.49%
2019 -31.61 Million USD 0.0%

Peer EBITDA Comparison of Leafly Holdings, Inc.

Name EBITDA EBITDA Difference
CannBioRx Life Sciences Corp. -22.13 Million USD 74.094%
BIMI International Medical Inc. -15.33 Million USD 62.617%
China Jo-Jo Drugstores, Inc. 1.22 Million USD 567.378%
Harrow Health, Inc. 8.625% Senior Notes due 2026 9.72 Million USD 158.974%
Harrow Health, Inc. 11.875% Senior Notes due 2027 9.72 Million USD 158.974%
Leafly Holdings, Inc. -5.73 Million USD -0.0%
LifeMD, Inc. -8.21 Million USD 30.194%
LifeMD, Inc. -8.21 Million USD 30.194%
TRxADE HEALTH, Inc. -13.72 Million USD 58.209%
PetMed Express, Inc. -394 Thousand USD -1355.33%
Walgreens Boots Alliance, Inc. -11.27 Billion USD 99.949%